Foundation Highlights Six Key Initiatives and Impact in Orange County and Beyond The Orange County Community Foundation (OCCF), one of the nation's largest and fastest-growing community foundations, announces Vision 2030, a dynamic five-year plan designed to amplify giving and support donors' philanthropic goals as well as address critical needs in Orange County. https://mma.prnewswire.com/media/2848066/Orange_County_Community_Foundation_logo_Logo.jpg “At the […]

Orange County's Premier Litigation Firm Celebrates 42 Years of Excellence with Spectacular New 45,000 Square Foot Office Space Callahan & Blaine, Orange County's premier trial and litigation firm, announced today its relocation on January 1, 2026, to a stunning new headquarters occupying the top two floors of the prestigious Newport Gateway building. The move marks

(NASDAQ:IDAI), IRVINE, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) — Boumarang, Inc. (“Boumarang”), a leader in hydrogen-powered autonomous aerial drone systems, today announced that it has filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC). This filing represents a significant milestone in Boumarang's strategic growth trajectory and demonstrates the Company's

20 Patents Support the Organization's Approach to Responsible AI, Designed to Accelerate Product Innovation that Help to Create New Financial Opportunities for Consumers Equifax® (NYSE: EFX) secured 27 patents in the second half of 2025, bringing the total number of new patents secured for the year to 62. Twenty of these new patents support the

The Board of Directors of FirstEnergy Corp. (NYSE: FE) today declared a quarterly dividend of 44.5 cents per share of outstanding common stock payable March 1, 2026, to shareholders of record at the close of business on February 6, 2026. https://mma.prnewswire.com/media/543843/FirstEnergy_Logo.jpg FirstEnergy is dedicated to integrity, safety, reliability and operational excellence. Its electric distribution companies

Eilean Therapeutics announced the advancement of ZE74-0282 into first-in-human clinical development. ZE74-0282 is a novel, highly selective inhibitor of the mutated Janus kinase 2 (JAK2) V617F variant and is being developed as a differentiated therapeutic candidate for myeloproliferative neoplasms, including myelofibrosis. https://mma.prnewswire.com/media/2189834/Eilean_Therapeutics_Logo.jpg Eilean Therapeutics announced the advancement of ZE74-0282 into first-in-human clinical development. ZE74-0282 was

Vancouver, British Columbia–(Newsfile Corp. – December 17, 2025) – NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) (“NervGen” or the “Company”), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other traumatic and neurologic disorders, today announced that it has filed a registration statement on Form F-10 (the “Registration Statement”) with

(NASDAQ:FRMI), BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) — Block & Leviton is investigating Fermi Inc. (Nasdaq: FRMI) for potential securities law violations. Investors who have lost money in their Fermi Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/frmi. What is this all

Boumarang, Inc. Files S-1 Registration Statement with the U.S. Securities and Exchange Commission Leading Developer of Hydrogen-Powered, AI-Enabled Autonomous Drone Systems Takes Strategic Step Toward Public Markets GlobeNewswire December 17, 2025 IRVINE, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) — Boumarang, Inc. (“Boumarang”), a leader in hydrogen-powered autonomous aerial drone systems, today announced that it has

Fermi Inc. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm's Investigation GlobeNewswire December 17, 2025 BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) — Block & Leviton is investigating Fermi Inc. (Nasdaq: FRMI) for potential securities law violations. Investors who have lost money in